HOTH (Hoth Therapeutics, Inc. Common Stock) Stock Analysis - SEC Filings

Hoth Therapeutics, Inc. Common Stock (HOTH) is a publicly traded Healthcare sector company. As of May 21, 2026, HOTH trades at $0.59 with a market cap of $11.72M and a P/E ratio of -0.66. HOTH moved +0.10% today. Year to date, HOTH is -43.41%; over the trailing twelve months it is -29.07%. Its 52-week range spans $0.49 to $3.80. Rallies surfaces HOTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find HOTH SEC filings?

Rallies organizes HOTH SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

HOTH Key Metrics

Key financial metrics for HOTH
MetricValue
Price$0.59
Market Cap$11.72M
P/E Ratio-0.66
EPS$-0.90
Dividend Yield0.00%
52-Week High$3.80
52-Week Low$0.49
Volume5.12K
Avg Volume0
Revenue (TTM)$0
Net Income$-12.47M
Gross Margin0.00%

Latest HOTH News

Recent HOTH Insider Trades

  • Knie Robb bought 25.00K (~$16.75K) on Aug 16, 2024.
  • Knie Robb bought 10.00K (~$3.90K) on Sep 19, 2022.
  • Knie Robb bought 10.00K (~$4.00K) on Sep 16, 2022.

HOTH Analyst Consensus

HOTH analyst coverage data. Average price target: $0.00.

Common questions about HOTH

Where can I find HOTH SEC filings?
Rallies organizes HOTH SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show HOTH 10-K and 10-Q filings?
Rallies organizes HOTH SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is HOTH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HOTH. It does not provide personalized investment advice.
HOTH

HOTH